The Obama Administration has made a much-anticipated announcement of the recipients of the $1 billion in new ACA therapeutic discovery project tax credits, which are designed to support research with significant potential to produce new therapies, address unmet medical needs, reduce the long-term growth of health care costs, or advance the goal of curing cancer within the next 30 years. The credit covers up to 50% of the cost of qualifying biomedical research, and is limited to firms with fewer than 250 employees. Almost 3,000 small biotechnology companies were awarded funds for a total of 4,606 projects.